BeiGene USA is a global oncology company dedicated to discovering and developing innovative cancer treatments that are both affordable and accessible to patients worldwide. With a diverse portfolio and a commitment to improving access to medicines, BeiGene is rapidly expanding its operations and capabilities. The company employs over 10,000 professionals across five continents, with administrative offices located in Basel, Beijing, and Cambridge, U.S. BeiGene values collaboration, bold ingenuity, and a patient-first approach, ensuring that its team is motivated and aligned in the fight against cancer.